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The Invariant U5 snRNA Loop 1 Sequence
Is Dispensable for the First Catalytic Step
of pre-mRNA Splicing in Yeast
Raymond T. O’Keefe, Christine Norman, splice site (Sawa and Abelson, 1992; Sawa and Shimura,
1992; Kandels-Lewis and Se´raphin, 1993; Lesser andand Andrew J. Newman
Guthrie, 1993). Recently, a highly conserved sequenceMRC Laboratory of Molecular Biology
in the U2/U6 helix structure has been shown by cross-Hills Road
linking to be associated with the 39 splice site after theCambridge CB2 2QH
first transesterification reaction (Newman et al., 1995).United Kingdom
In addition, the U5 snRNA has been shown to associate
with exon sequences at both the 59 and 39 splice sites
(Newman and Norman, 1992; Wyatt et al., 1992; Son-Summary
theimer and Steitz, 1993; Newman et al., 1995). Many
of these dynamic and specific RNA interactions, withWe have developed an in vitro reconstitution system
numerous protein interactions, contribute to splice siteto investigate the role of U5 snRNA in the two catalytic
recognition and may play central roles in the catalyticsteps of pre-mRNA splicing. The invariant U5 loop 1
steps of pre-mRNA splicing.is known to interact with exon sequences at the 59
Our interest is in the role of U5 snRNA during the twosplice site before the first catalytic step. Remarkably,
catalytic steps of splicing in the yeast Saccharomycesanalysis of U5 mutations in vitro reveals that the first
cerevisiae. The U5 snRNA gene is essential for growth intransesterification occurs accurately in the absence
yeast (Patterson and Guthrie, 1987). In addition, geneticof the U5 loop. Therefore this sequence is not an es-
depletion of U5 in yeast (Patterson and Guthrie, 1987;sential component of the spliceosomal active site for
Se´raphin et al., 1991) and in vitro depletion of U5 fromthe first catalytic step. The second catalytic step, al-
mammalian splicing extracts (Winkelmann et al., 1989;though strongly dependent on the presence of a U5
Lamm et al., 1991; Se´gault et al., 1995) have shown thatloop to tether the exon 1 splicing intermediate, is sur-
U5 is required for pre-mRNA splicing. U5 snRNAs fromprisingly tolerant of mutations in the invariant se-
diverse species contain an invariant loop 1 sequencequence.
(GCCUUUUAC) (Frank et al., 1994). Genetic experiments
in yeast first implicated this U5 invariant loop 1 sequence
Introduction in interactions with exon sequences at the 59 and 39
splice sites (Newman and Norman, 1992). Similar inter-
The removal of introns from pre-messenger RNA (pre- actions were also found to occur in a mammalian in vivo
mRNA) and ligation of the remaining exons are catalyzed system (Cortes et al., 1993). Site-specific cross-linking
within a multicomponent complex termed the spliceo- experiments in both mammalian (Wyatt et al., 1992; Son-
some. The spliceosome is composed of five small nu- theimer and Steitz, 1993) and yeast splicing extracts
clear RNAs (snRNAs) U1, U2, U5, U4/U6 and numerous (Newman et al., 1995) have revealed direct contacts
proteins that assemble together with pre-mRNA to facili- between nucleotides in the U5 invariant loop 1 sequence
tate the two transesterification reactions of splicing (re- and exon sequences at the 59 and 39 splice sites. These
viewed in Rymond and Rosbash, 1992; Moore et al., results have led to a model where the invariant loop 1
1993; Umen and Guthrie, 1995). Much work has focused sequence of U5 aligns the exons, following the first step
on the role of snRNAs in the spliceosome and their of splicing, targeting the 59 exon to the 39 splice site in
particular associations with the pre-mRNA and other the second transesterification reaction (Newman and
snRNAs during splicing (reviewed in Madhani and Guth- Norman, 1992; Sontheimer and Steitz, 1993). However,
rie, 1994). Through genetic and biochemical studies in it is not yet clear whether these interactions between
both mammalian and yeast systems, a picture is now the U5 snRNA and exon sequences ordinarily play any
emerging of spliceosomal snRNA interactions at the 59 role in specifying the splice sites or if they play an essen-
and 39 splice sites that may play crucial roles in the tial role in the transesterification reactions.
catalytic steps of splicing. First, U1 snRNA binds to the Functional snRNP reconstitution systems have been
pre-mRNA by interacting with sequences at the 59 splice invaluable for investigating the roles of U2 and U6 snRNA
site (Zhuang and Weiner, 1986; Se´raphin et al., 1988; sequences in the spliceosome (Fabrizio et al., 1989;
Siliciano and Guthrie, 1988). Next, U2 snRNA interacts McPheeters et al., 1989). Biochemical analysis of the
with the pre-mRNA via the branchpoint region in the role of U5 snRNP insplicing has been held back because
intron resulting in a bulged adenosine residue needed the U5 snRNA in splicing extracts has proved intractable
for attack of the 59 splice site (Query et al., 1994, and to oligonucleotide-directed ribonuclease H (RNaseH)
references therein). Following the binding of U1 and U2 ablation. In this study, we have inserted a sequence into
to the pre-mRNA, a pre-assembled U4/U6.U5 particle the U5 snRNA gene, rendering the U5 snRNA sensitive
associates with the pre-mRNA. A current model for to RNaseH ablation. This allowed efficient depletion of
snRNA interactions in the active spliceosome proposes U5 snRNA from yeast splicing extracts. In the absence
that U6 interacts with U2 sequences near the U2-intron of U5 snRNA spliceosome assembly is blocked and nei-
branchpoint helix to form a U2/U6 helix that may be a ther of the transesterification reactions can occur. Splic-
catalytic component of the spliceosome (Madhani and ing activity can be restored to depleted extracts by the
Guthrie, 1992). Also an invariant motif in U6 adjacent to addition of in vitro transcribed U5 snRNA. By assaying
mutations and deletions in U5 snRNA it was revealedthe U2/U6 helix contacts the pre-mRNA near the 59
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Figure 1. Predicted Secondary Structure of
S. cerevisiae U5 snRNA and Depletion of U5
snRNA from Yeast Splicing Extracts
Secondary structure of U5 snRNA adapted
from Frank et al. (1994) indicating the site and
sequence of the insert used as a target for
oligonucleotide directed RNaseH cleavage.
The secondary structure of the sequence in-
sert is not known and is arbitrarily drawn in
this diagram. The invariant 9 nucleotide loop
1 sequence of U5 is indicated with outlined
lettering. Targeting oligonucleotides were
59TTTCTCCCATGTTCGTTATA and 59GTAAA
AGGCAAGAACCTTCCCCAA and are repre-
sented by overbars. Inset: primer extension
of U5 andU6 snRNAs insplicing extracts from
yeast strains expressing U5 snRNA with a
sequence insertion (U5*) or wild-type U5.
Primer extension without targeting oligonu-
cleotide incubation (lanes 1 and 3). Primer
extension with targeting oligonucleotide in-
cubation (lane 2 and 4). The levels of U6
snRNA act as an internal standard (lanes 1–4).
that the invariant loop 1 sequence of U5 is not required U5 snRNA (Figure 1, compare lanes 3 and 4). For com-
parison, analysis of the U6 snRNA levels from both ex-for the first step of splicing. This loop 1 sequence, how-
ever, plays a critical role in the second transesterification tracts indicates that they were essentially unchanged
by incubation with the two targeting oligonucleotidesreaction. Deletions in the loop 1 sequence prevent U5
crosslinking to the exon sequence next to the 59 splice (Figure 1, lanes 1–4). This yeast strain, therefore, yields
extracts that can be specifically depleted of U5 snRNAsite. These results support the model in which the U5
loop 1 sequence is proposed to tether the free 59 exon, simply by incubating with two targeting oligonucleo-
tides.resulting from the first step of splicing, in the right orien-
tation for the second catalytic step (Newman and Nor-
man, 1992; Sontheimer and Steitz, 1993). We conclude Reconstitution of Splicing Activity with U5
that this invariant U5 snRNA loop 1 sequence cannot snRNA Produced In Vitro
be an essential component of the spliceosomal active To assay for reconstitution of splicing activity in de-
site for the first transesterification reaction. pleted extracts, in vitro transcribed wild-type U5 snRNA
[T7-U5 (wt)] was addedafter U5 depletion to allowrecon-
stitution of U5 snRNP particles. Following reconstitu-Results
tion, radioactively labeled actin pre-mRNA was added
to initiate splicing. Depletion of U5 snRNA from thisDepletion of U5 snRNA from Yeast
extract results in essentially complete abolition of splic-Splicing Extracts
ing activity (Figure 2, lane 2). When different amountsTo circumvent the difficulty in depleting U5 from splicing
of T7-U5 (wt) were added to U5 depleted extract (Figureextracts, we have constructed a yeast strain by plasmid
2, lanes 3–11) splicing activity was restored to levelsshuffle (Boeke et al., 1984) that harbors a modified U5
greater than that of the starting extract (Figure 2, lanegene as the sole source of U5 snRNA (see Experimental
1). Addition of either in vitro transcribed U6 or U1 snRNAProcedures). This modified U5 contains an arbitrarily
to U5 depleted extract did not restore splicing activitychosen 30 nucleotide sequence insertion between nu-
(Figure 2, lanes 12 and 13) indicating that the reconstitu-cleotides 85 and 86 in stem 1 (Figure 1). Extracts made
tion of splicing activity observed was U5 snRNAspecific.from this strain can be efficiently depleted of U5 snRNA
Analysis by native gel electrophoresis of U5 depletedwith two oligonucleotides targeted to a portion of the
extracts revealed that only presplicing complexes (con-30 nucleotide sequence insertion and flanking regions
taining U1 and U2) are formed in the absence of U5.of U5 snRNA. Primer extension analysis of total RNA
However, reconstitution of U5 depleted extract with T7-isolated from an extract made from this strain indicates
U5 (wt) allowed the formation of splicing complexes thatthat there is efficient degradation of this modified U5
are typical of normal splicing reactions (data not shown).when the extract is incubated with the two targeting
oligonucleotides (Figure 1, compare lanes 1 and 2),
whereas incubation with either oligonucleotide alone Mutations and Deletions of U5 snRNA: U5 loop 1
is Dispensable for 59 Splice Site Cleavagegave incomplete U5 digestion (data not shown). These
oligonucleotides, however, do not target the U5 snRNA This in vitro reconstitution system for U5 allows the
functional analysis of U5 snRNA mutations or deletionsin an extract from a similar strain expressing wild-type
Yeast U5 snRNP Reconstitution
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Table 1. Viability of U5 Deletions and Mutations
Nucleotides Deleted Growth on 5-FOAa at 308C
None Yes
166–175 (Sm site) Yes
41–74 Yes
95–99 No
93–101 No
88–106 No
84–110 No
41–74, 93–101 No
Reverse complement 92–102 No
91–103 replaced by GCAA No
91–103 replaced by UUCG No
a 5-fluoro-orotic acid
the Sm site of the Xenopus U5 snRNA is required for
Sm protein binding (Jarmolowski and Mattaj, 1993) and
Sm proteins are essential for the formation of functional
U5 snRNPs in mammalian extracts (Se´gault et al., 1995).
Our results indicate that binding of the core Sm proteins
to U5 may not be necessary for U5 function in yeast or
that the Sm proteins may still bind to U5 snRNA lacking
an authentic Sm site. There are Sm-like sequences in
the U5 long form, which we have used in this study,
downstream of the Smsite that could possibly substitute
for the true site.
U5 sequences containing mutations or deletions were
transcribed in vitro and added to an extract depleted of
U5 to test their ability to splice pre-mRNA. The two
deletions that maintained growth in vivo as the sole
source of U5, T7-U5 (del. 166–175, Sm site), and T7-U5
(del. 41–74), reconstituted both steps of splicing (Figure
3, lanes 7 and 8). Deletions of nucleotides 88–106 or
84–110, which removed the whole conserved loop 1 and
portions of the stem 1, resulted in very low levels of
splicing activity (Figure 3, lanes 5 and 6) perhaps re-
flecting the inability of some protein or proteins to bind
to the U5 snRNA. Alternatively, these deletions could
cause a change in structure of the U5 snRNA that may
prevent either the formation of the U4/U6.U5 tri-snRNP
Figure 2. Reconstitution of Splicing Activity in U5 Depleted Extracts particle or the assembly of this particle into a splice-
Using In Vitro Transcribed U5 snRNA. osome.
Splicing activity of extract prior to U5 depletion (lane 1). Extract Interestingly, deletions of the conserved loop 1 se-
depleted of U5 (lane 2). Addition of 1–100 nM of T7-U5 (wt) (lanes
quences 95–99or 93–101, containing nucleotides known3–11). Addition of in vitro transcribed U6 snRNA (lane 12) and U1
to interact with exon sequences at the 59 and 39 splicesnRNA (lane 13). pBR322 MspI end-labeled size markers (lane 14).
sites (Newman and Norman, 1992; Wyatt et al., 1992;
Sontheimer and Steitz, 1993; Newman et al., 1995), were
that are lethal in vivo as the sole source of U5. Various permissive for the first step of splicing, as seen by an
mutations and deletions were made in the U5 sequence accumulation of intron–exon 2 and exon 1 intermediates
and tested as the sole source of U5 in vivo by plasmid (Figure 3, lanes 3 and 4). The second step of splicing
shuffle (Table 1). Of all the mutations and deletions made with these deletions, however, was severely inhibited.
in U5, a deletion of the Sm site and a deletion of a Analysis by primer extension of the intron-exon 2 inter-
variable stem/loop structure from nucleotides 41–74 mediates that resulted from T7-U5 (del. 93–101) indi-
that is present in only a subset of fungal U5 snRNAs cated that 59 splice site cleavage in the presence of this
(Frank et al., 1994) were the only two viable as the sole deletion occurred accurately at the authentic site (data
source of U5. The variable stem/loop structure has been not shown). This rules out the possibility that the second
shown previously to be dispensable for U5 function in transesterification was prevented simply because of ab-
vivo (Frank et al., 1994). The growth of cells without the errant 59 splice site cleavage, which in principle might
Sm site of U5 was surprising. U5 snRNA exists in two have generated dead-end lariat intermediates via cleav-
forms in budding yeast, a long and a short form (Pat- age at the 59 side of residues other than G. Accumulation
terson and Guthrie, 1987). Previous studies have shown of splicing intermediates was also observed when the
that deletion of the Sm site from the short form of U5 loop 1 sequence was deleted and replaced with se-
quences known to form tetraloops (Heus and Pardi,snRNA is lethal (Jones and Guthrie, 1990). In addition,
Cell
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tuted both steps of splicing (data not shown). It may be
significant that these two U5 variants retain the wild-
type loop size of 11 nucleotides.
Quantitation of splicing intermediates and products
confirms the conclusions made above about the behav-
ior of the U5 mutations and deletions and reveals addi-
tional information (Table 2). It is apparent that all of the
U5 variants resulted in lower total splicing activity. This
could reflect suboptimal spliceosome assembly of these
U5 variants and/or reduced catalytic activity. Quantita-
tion reveals that the levels of step 1 products of some
loop 1 deletions are close to the levels of step 2 products
of T7-U5 (wt) indicating that the major defect is in step
2. In any case, the data make it absolutely clear that U5
mutants that lack the loop 1 sequence reconstitute the
first catalytic step.
Interactions of U5 Mutants and Deletions with
the Exon Sequence at the 59 Splice Site
One of the proposed functions of the conserved loop 1
sequence of U5 is to “tether” the 59 exon following the
first step of splicing and then align the two exons for the
second catalytic step of splicing. This model is based on
both genetic and cross-linking studies that have shown
that the loop 1 sequence of U5 interacts with exon se-
quences at the 59 and 39 splice sites during splicing
(Newman and Norman, 1992; Wyatt et al., 1992; Son-
theimer and Steitz, 1993; Newman et al., 1995). It is
possible, therefore, that one reason why some of the
deletions or mutations in U5 do not carry out the second
step of splicing may be because they do not interact
with the 59 exon properly, consequently preventing the
Figure 3. In Vitro Splicing Activity of U5 snRNA Mutations and Dele- alignment of the two exons for the second catalytic step.
tions In an attempt to address this idea we produced, by
Extract depleted of U5 (lane 1). Reconstitution with T7-U5 (wt) (lane ligation in vitro, CYH2 pre-mRNA with a single 4-thio-
2). Reconstitution with in vitro transcribed U5 mutations or deletions uridine (4-thioU) residue at position (21) in exon 1 to
(lanes 3–11). The 59 fragment of U5 snRNA without the loop 1 se-
determine whether any of the U5 snRNA mutants orquence (lane 12). The 39 fragment of U5 snRNA without the loop 1
deletions could interact with the exon sequence next tosequence (lane 13). Both 59 and 39 fragments of U5 snRNA annealed
the 59 splice site. Extracts depleted of U5 snRNA weretogether without the loop 1 sequence (lane 14). pBR322 MspI end-
labeled size markers (lane 15). reconstituted with different U5 mutations or deletions
and incubated with this pre-mRNA to allow splicing to
occur. The splicing reactions were then UV irradiated
with 365 nm light to induce 4-thioU-based cross-link1991; Varani et al., 1991) (Figure 3, lanes 10 and 11). An
additional striking demonstration that the loop 1 se- formation and the deproteinized RNA was fractionated
by electrophoresis (Figure 4A). Parallel reactions werequence of U5 is not required for the first step of splicing
involved making U5 snRNA in two pieces lacking the carried out with pre-mRNA containing an unmodified U
at position (21) in exon 1 to control for the site-specific-connecting loop 1 sequence. Nucleotides 1–91 and 103–
214 of U5 were transcribed in vitro separately with nucle- ity of cross-linking. Splicing reactions containing control
pre-mRNA with an unmodified U at position (21) in exonotide 91 changed to a C and nucleotide 103 changed
to a G to provide a stable stem 1 structure. These RNAs 1 did not result in any cross-links, either in depleted
extract (Figure 4A, lane 1) or with any of the U5 snRNAson their own did not reconstitute splicing activity (Figure
3, lanes 12 and 13). However, when annealed together, (Figure 4A, lanes 2–6). However, when splicing reactions
were carried out with the CYH2 pre-mRNA with a 4-thioUreconstitution of the first step of splicing was observed
but the second step was severely inhibited (Figure 3, residue at position (21) in exon 1, a number of different
cross-links were produced in each reaction (Figure 4A,lane 14). This proved dramatically that the invariant loop
1 sequence of U5 is not required for the first step of lanes 7–12). One major cross-link species (b) and two
minor species (c and d) occurred in splicing reactionssplicing.
Mutation of the 11 nucleotide loop 1 sequence (nucle- depleted of U5, incubated with 4-thioU containing pre-
mRNA and UV irradiated without any form of in vitrootides 92–102) to its reverse complement 59ACG-
GAAAAUGG39 (RC 92–102) reconstituted the first step transcribed U5 (Figure 4A, lane 7). These species were
also present in each of the reactions where different U5of splicing and remarkably this mutant also supports
the second step (Figure 3, lane 9). In addition, mutation snRNAs were assayed. In only two cases are there any
additional cross-links. Addition of T7-U5 (wt) to a de-of the four uridines in loop 1 to guanosines also reconsti-
Yeast U5 snRNP Reconstitution
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Table 2. Quantitation of In Vitro Splicing Activity
U5 Sequences Step 1 Step 2 Total Splicing Step 1/Step 2
T7-U5 (WT) 0.25 0.75 1.00 0.33
Del. 95–99 0.73 0.12 0.85 6.08
Del. 93–101 0.63 0.11 0.74 5.73
Del. 88–106 0.06 0.02 0.08 3.00
Del. 84–110 0.07 0.02 0.09 3.50
Del. 166–175 0.19 0.40 0.59 0.46
Del. 41–74 0.14 0.31 0.45 0.45
RC 92–102 0.25 0.38 0.63 0.66
91–103 replaced by GCAA 0.64 0.05 0.69 12.80
91–103 replaced by UUCG 0.57 0.05 0.62 11.40
U5 59 half 0.00 0.00 0.00 —
U5 39 half 0.00 0.00 0.00 —
U5 59 and 39 half 0.43 0.02 0.45 21.50
Quantitation is the result of data obtained from a Molecular Dynamics Phosphorimager and is the average of three experiments identical to
Figure 3. The relative values presented in the table have been normalized for the amount of substrate in each lane, and the background of
the depletion lane has been subtracted. The value of total splicing activity for U5 WT has been arbitrarily set at 1.00.
pleted extract (Figure 4A, lane 8) and of T7-U5 (RC 92– 8–12), indicating that this mutant version of U5 can also
cross-link to the pre-mRNA at position (21) in exon 1.102) (Figure 5A, lane 11) both resulted in another cross-
linked species (a). In each case the exon 1 oligonucleotide causes only a
slight shift in the mobility of the U5 cross-link to the pre-To determine the identity of each of these cross-links,
we chose the two reactions that produced all cross- mRNA (Figure 4B, lanes 4 and 10). The two minor cross-
links (c and d) are not definitively identified by thislinked species (Figure 4A, lanes 8 and 11) and subjected
them to RNaseH analysis with oligonucleotides targeted RNaseH analysis.
Another cross-linked species that appears followingto U1 and U5 snRNAs, as well as oligonucleotides tar-
geted to the pre-mRNA (Figure 4B). In the reactions that reconstitution with each of these U5 sequences and UV
irradiation runs very close to the pre-mRNA and cancontained T7-U5 (wt), the slowest migrating cross-link
(a) was targeted by the U5 oligonucleotide (Figure 4B, only be observed by 2-dimensional electrophoresis
(Newman et al., 1995) (Figure 5). This cross-link resultslane 3) and all of the pre-mRNA oligonucleotides (Figure
4B, lanes 4–6). This cross-link, therefore, is U5 cross- from the interaction between the U5 snRNA loop 1 and
the exon 1 intermediate produced by the first step oflinked to the pre-mRNA at position (21) inexon 1. Cross-
link (b) was targeted by the U1 oligonucleotide (Figure splicing. To facilitate visualization of this cross-linked
species, we used a substrate carrying a G→C mutation4B, lane 2) and all the pre-mRNA oligonucleotides (Fig-
ure 4B, lanes 4–6). This cross-link, therefore, is U1 cross- at the last nucleotide of the intron, which blocks the
second catalytic step and causes accumulation of splic-linked to the pre-mRNA at position (21) in exon 1. In
reactions that contained the T7-U5 (RC 92–102), the two ing intermediates. Both T7-U5 (wt) (Figure 5A) and T7-U5
(RC 92–102) (Figure 5B) were able to form this cross-linkcross-links (a and b) were likewise targeted by the U5,
U1, and pre-mRNA oligonucleotides (Figure 4B, lanes (indicated with arrows in Figures 5A and 5B). Reactions
Figure 4. In Vitro Splicing and Photoacti-
vated Cross-Linking of pre-mRNAs Carrying
a 4-thioU Residue at Position (21) in Exon 1
in the Presence of U5 snRNA Mutations and
Deletions
(A) Extract depleted of U5 was reconstituted
with different in vitro transcribed U5 snRNA
mutations or deletions, incubated with CYH2
pre-mRNA with either unmodified U (lanes
1–6) or a single 4-thioU (lanes 7–12) resi
due at position (21) in exon 1, and UV irradi-
ated. pBR322 MspI end-labeled size markers
(lane 13).
(B) Identification of cross-linked species pro-
duced in reconstitution reactions with T7-U5
(wt) (lanes 1–6) and T7-U5 (RC 92–102) (lanes
7–12) by RNaseH analysis. Oligonucleotides
were targeted to the following RNAs: no oligo
control (lanes 1 and 7), U1 snRNA (lanes 2
and 8), U5 snRNA (lanes 3 and 9), exon 1
(lanes 4 and 10), intron (lanes 5 and 11), and
exon 2 (lanes 6 and 12). pBR322 MspI end-
labeled size markers (lane 13).
In both (A) and (B) the lariat intron product and the lariat intron–exon 2 intermediate are not visible because the only radioactive phosphate
in the pre-mRNA is in exon 1. The exon 1 intermediate and mRNA product are not shown.
Cell
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Figure 5. Visualization of Cross-Linked Species Following 2-D Elec-
trophoresis
(A) Reconstitution with T7-U5 (wt) resulted in a cross-link of U5
to the exon 1 intermediate running as a spot behind the diagonal
(identified with arrow).
(B) Reconstitution with T7-U5 (RC 92–102) (U5:exon1 cross-link
identified with arrow).
(C) Reconstitution with T7-U5 (del. 93–101).
(D) Control reconstitution with water. In (A)–(D), (a) is a cross-link
between U5 and the pre-mRNA, and (b) is a cross-link between U1
Figure 6. Primer Extension Mapping of Cross-links between4-thioUand the pre-mRNA.
at Position (21) in Exon 1 and U5 snRNAs
(A) T7-U5 (wt) and CYH2 pre-mRNA with a single 4-thioU residue
containing T7-U5 (del. 93–101) (Figure 5C) or lacking U5 at position (21) in exon 1 (lane 5), T7-U5 (wt), and CYH2 pre-mRNA
with an unmodified U residue at position (21) in exon 1 (lane 6), andsnRNA (Figure 5D) are not able to form this cross-link.
no T7-U5 (wt) and CYH2 pre-mRNA with a single 4-thioU residue atThis indicates that in the reconstitution system T7-U5
position (21) in exon 1 (lane 7). Dideoxynucleotide sequencing(wt) and T7-U5 (RC 92–102) can interact with the exon
tracks produced using T7-U5 (wt) as template are displayed (lanes
1 intermediate in the same way as endogenous U5 1–4) as reference for primer extension mapping.
snRNA in standard splicing extracts. By comparing (B) T7-U5 (RC 92–102) and CYH2 pre-mRNA with a single 4-thioU
these cross-linking results with the splicing patterns of residue at position (21) in exon 1 (lane 5), T7-U5 (RC 92–102) and
CYH2 pre-mRNA with an unmodified U residue at position (21) inthe mutants and deletions of U5, it is clear that cross-
exon 1 (lane 6), and no T7-U5 (RC 92–102) and CYH2 pre-mRNAlinking of U5 snRNA to position (21) of exon 1 in the
with a single 4-thioU residue at position (21) in exon 1 (lane 7).pre-mRNA and in the exon 1 intermediate correlates
Dideoxynucleotide sequencing tracks produced using T7-U5 (RC
with the ability of spliceosomes to complete the second 92–102) as template are displayed (lanes 1–4) as reference for primer
catalytic step of splicing. Fractionation by gel filtration extension mapping. Arrows indicate primer extension stops that lie
of spliceosomes lacking U5 loop 1, in which contact one nucleotide from the actual site of cross-link.
between position (21) of exon 1 and U5 snRNA is unde-
tectable and which fail to carry out the second transes-
terification, indicates that the exon 1 intermediate is and incubated with CYH2 pre-mRNA with a 4-thioU at
position (21) in exon 1. These reactions were UV irradi-apparently still associated with the spliceosome (data
not shown). It is currently unclear, however, whether in ated and theRNA deproteinized.The U5-containing spe-
cies were captured using a biotinylated oligonucleo-these circumstances exon 1 is still tethered by specific
interactions with any component of the spliceosome. tide complementary to U5 and streptavidin-conjugated
paramagnetic particles. Following electrophoresis of theFinally, the T7-U5 (wt) cross-links to position (21) in
exon 1 of the pre-mRNA were mapped by primer exten- captured RNA, the U5:pre-mRNA cross-linked species
and the RNA in the corresponding positions of the con-sion. Extract depleted of U5 snRNA was divided into
three aliquots. One aliquot was reconstituted with T7- trol lanes were recovered by electroelution. These sam-
ples were then subjected to primer extension analysisU5 (wt) and incubated with CYH2 pre-mRNA with a
4-thioU at position (21) in exon 1. The second aliquot with a primer specific for the 39 end of U5 snRNA and
the products displayed next to a sequence ladder for T7-was reconstituted with T7-U5 (wt) and incubated with
CYH2 pre-mRNA with an unmodified U at position (21) U5 (wt) (Figure 6A). Assuming that reverse transcriptase
stops one position before a cross-linked nucleotide, thein exon 1. The third aliquot was reconstituted with water
Yeast U5 snRNP Reconstitution
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cross-link between T7-U5 (wt) and the pre-mRNA at site cleavage still occurs. This is especially surprising
in view of the evidence from cross-linking experimentsposition (21) in exon 1 maps to positions U96 and U97
(Wyatt et al., 1992; Sontheimer and Steitz, 1993; New-in the highly conserved loop 1 sequence of U5 (Figure
man et al., 1995) and in vivo studies (Newman and Nor-6A, lane 5). This corresponds exactly to the nucleotides
man, 1991, 1992; Cortes et al., 1993) that ordinarily thein endogenous U5 that cross-link to this pre-mRNA in
interaction of U5 loop 1 with exon sequences at the 59standard yeast splicing extracts (Newman et al., 1995).
splice site precedes the first catalytic step. Such find-No primer extension stops are observed in the control
ings suggested that this interaction might be a pre-reactions (Figure 6A, lanes 6 and 7). These results indi-
requisite for 59 splice site cleavage. Our current findings,cate that the reconstituted T7-U5 (wt) contacts the pre-
on the contrary, point to the conclusion that the primarymRNA in precisely the same way as the endogenous
role of the invariant U5 loop sequence is in tetheringU5 in a standard splicing extract.
the 59 exon intermediate and orienting it correctly forThe T7-U5 (RC 92–102) was the only other U5 tested
nucleophilic attack at the 39 splice site in the secondthat resulted in a cross-link to the 4-thioU at position
catalytic step. In this view the establishment of U5(21) in exon 1. This cross-link maps to positions A96
snRNA–exon 1 interactions prior to 59 splice site cleav-and A97 in the mutant U5 sequence (Figure 6B, lane 5).
age serves to preclude possible loss of the exon 1 inter-These two positions correspond exactly to the positions
mediate from the active core of the spliceosome.that are cross-linked when the T7-U5 (wt) is used. No
Previous in vivo U5 depletion studies and in vitro com-primer extension stops are observed in the control reac-
plementation experiments have hinted that the first steptions (Figure 6B, lanes 6 and 7). Therefore, it appears
of splicing may be able to occur without U5 (Pattersonthat even this drastic change in the U5 loop 1 sequence
and Guthrie, 1987; Winkelmann et al., 1989). These stud-does not influence the sites at which it cross-links to
ies, however, were unable to address directly the mech-the pre-mRNA at position (21) in exon 1.
anism by which this might occur. In light of the present
results it is possible to speculate how these two experi-
Discussion mental situations gave this result. Fusion of the U5
snRNA gene to the GAL1 control region and growth of
We have been able to efficiently deplete U5 snRNA cells on glucose gradually depletes U5 snRNA from
from yeast splicing extracts by inserting a sequence yeast by dilution and degradation (Patterson and
into U5 snRNA thus rendering it susceptible to oligonu- Guthrie, 1987). Degradation of the U5 snRNA in the ex-
cleotide-targeted degradation by RNaseH. Functional posed loop 1 region might result in the appearance of
U5 snRNPs were then reconstituted by addition of U5 splicing intermediates. In vitro complementation assays
snRNA produced in vitro, as demonstrated by restora- utilizing micrococcal nuclease-treated mammalian ex-
tion of splicing activity. The behavior of U5 snRNA pro- tracts (Winkelmann et al., 1989) revealed that under
certain conditions addition of only U1.U2 and U4/U6duced in vitro was indistinguishable from endogenous
snRNP fractions to these extracts permitted the firstU5 snRNA present in wild-type splicing extracts in that it
step of splicing but not the second. This might arisewas able to form similar splicing complexes and support
if the micrococcal nuclease-treated extracts containedboth steps of splicing. The reconstituted U5 snRNA in-
trace amounts of U5 snRNPs with the exposed loop 1teracted with the pre-mRNA and the 59 exon in the region
sequence digested but the rest of the snRNP intact.investigated [position (21) in exon 1] inan identical man-
Given the phylogenetic invariance of the U5 snRNAner to that of endogenous U5 snRNA in yeast (Newman
loop 1 motif, it is at first sight surprising that U5 mutants,et al., 1995) and mammalian (Sontheimer and Steitz,
such as RC 92–102, inwhich the loop sequence is drasti-1993) splicing reactions. These results suggest that re-
cally altered, can carry out both steps of splicing andconstituted U5 snRNPs are functionally equivalent to
interact with the pre-mRNA at position (21) in exonthe authentic particles in yeast splicing extracts.
1 with the same loop 1 positions as the wild-type U5
sequence. However, there are precedents which in-
The Role of U5 snRNA in pre-mRNA Splicing dependently establish that the U5 loop can be altered
The U5 snRNA reconstitution system allows us to inves- radically without abolishing splicing activity: loop se-
tigate the consequences of U5 mutations and deletions quences containing multiple mutations have been
on the two catalytic steps of pre-mRNA splicing. Pre- shown to generate mRNA in vivo (Newman and Norman,
viously, U5 mutations and deletions could only be as- 1991, 1992). Together, these findings suggest that any
sayed in vivo (Jones and Guthrie, 1990; Frank et al., essential interactions between loop 1 and other spliceo-
1994). Such viability assays resulted in the identification somal components must be very tolerant of loop 1 se-
of essential sequences in U5 snRNA but could not di- quence mutations.
rectly address their role in the two steps of splicing. How can one reconcile the fact that the U5 mutant
Functional analysis in vitro of U5 mutations and dele- RC 92–102 is lethal in vivo as the sole source of U5,
tions that are lethal in vivo has provided new insights despite the fact that this mutation supports both cata-
into the role of U5 in splicing. It is clear that the U5 lytic steps in vitro? It may be significant that spliceo-
snRNA is essential for spliceosome assembly and func- somes harboring this altered U5 loop accomplish the
tion. However, the invariant U5 snRNA loop 1 sequence second catalytic step less efficiently than the wild-type
(GCCUUUUAC) is dispensable for the first catalytic step loop. Possibly in vivo the U5 mutant RC 92–102 cannot
of splicing. This is most clearly demonstrated by the generate an adequate level of mRNA from one or more
finding that when the U5 snRNA is made in two frag- of the essential intron-containing genes in the yeast
genome.ments, lacking the connecting loop 1 sequence,59 splice
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Mechanistically the fact that 59 splice site cleavage to the EBS1–IBS1 contacts in group II splicing (Newman
and Norman, 1992; Sontheimer and Steitz, 1993). In lightcan take place without U5 loop 1 implies that this invari-
ant sequence is not an essential part of the spliceosomal of the data presented here, it is apparent that there are
both differences and similarities between these interac-active site for the first step of splicing. A model for a
two-metal-ion mechanism for catalytic RNA has been tions in group II and pre-mRNA splicing. In yeast pre-
mRNA splicing, contact between the invariant U5 loopproposed for the spliceosome, and other RNA catalyzed
reactions, where the bases flanking the scissile phos- 1 and exon sequences adjacent to the 59 splice site is
clearly dispensable for accurate 59 splice site cleavage.phates are oriented by RNA functional groups forming
three binding sites (Steitz and Steitz, 1993). Based on This is in contrast to the group II EBS1–IBS1 interaction
that has been shown to be a pre-requisite for 59 splicecross-linking studies in mammalian splicing extracts,
which demonstrated interactions between the invariant site recognition and cleavage (Jacquier and Michel,
1987; Jacquier and Jacquesson-Breuleux, 1991). On theU5 loop 1 sequence and exon sequences at the 59 and 39
splice sites, itwas proposed that the U5 loop 1 sequence other hand, U5 loop 1 is required in the second transes-
terification, presumably to tether and align the 59 exonmay contribute to these binding sites (Sontheimer and
Steitz, 1993). For the first step of splicing the first two for ligation to the 39 exon. This capacity also appears
to be carried out by EBS1 in group II introns. So theuridines of the sequence GCCUUUUAC were proposed
to form site 1 of the two-metal-ion active site. The data function of the EBS1–IBS1 interaction in sequence-spe-
cific 59 splice site recognition may have been delegatedpresented here, indicating that the U5 loop 1 sequence
is not required for the first step of splicing, do not sup- to other factor(s) in the spliceosome that presumably
recognize conserved intron sequences at the 59 spliceport this proposal in its simplest form. Conceivably in
the absence of the U5 loop 1 sequence some other RNA site.
or protein component of the spliceosome can act as a
surrogate site 1. Our data, however, do fit in with the
How is the 59 Splice Site Recognized?proposal that in the second step of splicing the U5 loop
The data presented here leave open the question of how1 interacts with the 39 exon to contribute to site 3. They
the 59 splice site is identified and accurately targetedare also consistent with the suggestion that following
by the 29 hydroxyl of the branch-site adenosine in thethe first step of splicing the U5 loop 1 would comprise
first catalytic step. Although U1 snRNA certainly playssite 1 for the second step of splicing. Clearly further
a role in 59 splice site recognition early in spliceosomeexperimental analysis of the active site of the spliceo-
assembly (Zhuang and Weiner, 1986; Se´raphin et al.,some is needed to determine which RNA components
1988; Silicianoand Guthrie, 1988), it is clear that 59 splicecould contribute to the three sites in this model.
site cleavage can be uncoupled from U1 snRNA interac-
tions with the substrate (Se´raphin and Rosbash, 1990).
In any case, there is now clear genetic and biochemicalU5 snRNA Loop 1 Parallels in Group II
Intron Splicing evidence that an interaction between an invariant ele-
ment in U6 snRNA and conserved nucleotides at the 59Many of the RNA interactions found to be required for
spliceosomal pre-mRNA splicing have been likened to splice site plays a role in determining the specificity of
59 splice site cleavage (Sawa and Abelson, 1992; Sawathe RNA interactions that facilitate the self-splicing of
group II introns. Furthermore, both pre-mRNA splicing and Shimura, 1992; Kandels-Lewis and Se´raphin, 1993;
Lesser and Guthrie, 1993). The U1 and U6 interactionsand group II intron splicing take place via a two-step
transesterification reaction characterized by a branched with the substrate appear to be mutually exclusive
(Konforti et al., 1993) implying some sort of handing-offlariat intermediate (reviewed in Weiner, 1993; Wise,
1993; Madhani and Guthrie, 1994; Michel and Ferat, process in which the 59 splice site is transferred from
U1 to U6. Mutational analysis of the invariant U5 snRNA1995). These similarities have given rise to the proposal
that pre-mRNA splicing and group II intron splicing are loop sequence showed that interactions between the
U5 loop and the pre-mRNA in the vicinity of the authenticevolutionarily related (Cech, 1986; Sharp, 1991). One
RNA interaction that has been proposed to be similar 59 splice site can activate aberrant 59 cleavage sites,
implying a potential role for U5 in influencing cleavagebetween these two modes of splicing involves RNA con-
tacts with the exon sequence adjacent to the 59 splice site specificity (Newman and Norman, 1991, 1992). Acti-
vation of aberrant cleavage sites by U5 snRNA loopsite. In group II intron splicing an RNA loop sequence
in the intron, termed exon binding site 1 (EBS1), contacts mutations, however, proved to be strictly dependent on
the presence of a mutation of the 59 terminal G residuesequences adjacent to the 59 splice site termed intron
binding site 1 (IBS1) through contiguous classical (Wat- of the intron, suggesting that recognition of this G resi-
due (by some factor other than U1 snRNA) is ordinarilyson–Crick and wobble) base pairs (Jacquier and Michel,
1987). These base-pairing contacts, EBS1–IBS1, are an crucial for splice site definition. In any case the results
presented in this paper show clearly that 59 splice siteimportant component of the interactions that define the
59 splice site in group II introns and are also critical for cleavage can be uncoupled from the invariant U5 snRNA
loop sequence without affecting accuracy or specificity,retaining the 59 exon for ligation to the 39 exon in the
second catalytic step (reviewed in Michel and Ferat, further demonstrating that U5 snRNA does not make an
essential contribution to 59 splice site definition.1995). In pre-mRNA splicing, non-Watson–Crick interac-
tions between exon sequences adjacent to the 59 splice Although the interactions of components of the
spliceosome with 59 splice sites have now been ana-site and the invariant U5 loop 1 sequence have been
proposed to be evolutionarily and functionally related lysed in some detail, the factor(s) that must recognize
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constructed by transformation of BSY113 with m571 or pROK8 plas-the conserved GU at the cleavage site still remains to
mid, respectively, and growth on 5-fluoro-orotic acid containingbe identified. The highly conserved U5 snRNP protein
medium to select against cells harboring the URA3 containing plas-PRP8 (and its mammalian counterpart p220) is so far the
mid. To test growth of yeast with U5 snRNA mutations and deletions
best candidate for this role: cross-linking experiments BSY113 was transformed with m571 based plasmids resulting from
show that PRP8/p220 contacts exon sequences and the in vitro mutagenesis and grown on 5-fluoro-orotic acid containing
medium.GU dinucleotide at the 59 splice site (Wyatt et al., 1992;
Teigelkamp et al., 1995; Reyes et al., 1996). This protein,
In Vitro Transcription of RNAtherefore, is well placed to play a role in targeting the GU
Full-length and mutant yeast U5 snRNAs were transcribed from PCRfor attack by the 29-OH of the branchpoint adenosine.
products containing the T7 promoter. Transcription reactions of 200
ml consisting of 40 mM Tris–Cl (pH 8), 2 mM spermidine, 10 mM
Experimental Procedures DTT, 20 mM MgCl2, 1 mM each NTP, 30 mg PCR template, 165 U
RNasin (Promega) and 350 U T7 RNA polymerase (Pharmacia Bio-
Plasmids tech) were incubated for 2 hr at 378C. Actin pre-mRNA was produced
The m571 plasmid is pRS314 (Sikorski and Hieter, 1989) carrying by run-off transcription in 10 ml reactions consisting of 40 mM Tris–Cl
the gene SNR7 for U5 snRNA. The pROK8 plasmid was constructed (pH 7.5), 2 mM spermidine, 10 mM DTT, 10 mM NaCl, 6 mM MgCl2,
by site-directed mutagenesis of m571 plasmid with oligonucleotide 0.5 mM ATP, CTP, and GTP, 25 mM UTP, 3 ml [a-32P]UTP (400 Ci/
94–4306. The p283 plasmid is pGEM-1 with an AluI fragment of the mmol), 2 mg linearized plasmid, 16.5 U RNasin, 70 U T7 RNApolymer-
yeast actin gene inserted at the SmaI site in the T7 orientation. This ase that were incubated for 30 min at 378C. All RNA was then purified
plasmid was linearized with BamHI for run-off transcription. The by denaturing PAGE and electroelution (Amicon Centrilutor; Centri-
k461 plasmid is pRS316 carrying the gene SNR19 for U1 snRNA. con C30 columns).
Site-specific Labeling and RNA LigationOligonucleotides
Synthetic CYH2 pre-mRNA containing a single 4-thioU residue atThe 30 nucleotide sequence insertion into the U5 snRNA gene was
position (21) in exon 1 and a single 32P label 59 of the 4-thioU wasmade by site-directed mutagenesis of m571 plasmid with oligonu-
made by ligation according to Newman et al. (1995).cleotide 94–4306, 59AAGGCAAGAA CCTTCCCCAACTCCCGCAGTT
TCTTTTCTCCCATGTTCGTTATA. Oligonucleotides used for RNaseH
cleavage of U5 snRNA with the 30 nucleotide sequence insertion Splicing Extract Preparation and In Vitro
were 94–6299, 59TTTCTCCCATGTTCGTTATA and 95–2211, 59GTAA Depletion-Reconstitution Reactions
AAGGCAAGAACCTTCCCCAA. Oligonucleotides used for in vitro Splicing extracts were prepared from S. cerevisiae strains ROK8
mutagenesis of the U5 snRNA gene in plasmid m571 to produce and M571 essentially according to Newman et al. (1985). Depletion
U5 deletions and mutations were95–032, 59GGCAGAAAAGTTGGCA of U5 snRNA from extracts made from the ROK8 strain was per-
AGCCCACA (del. 166–175); 95–033, 59CGGATGGTTCTGAAGAACC formed at 348C for 30 min. in a reaction containing 50% extract in
ATGTT (del. 93–101); 95–1050, 59ATGTTCGTTATGATGTTGACC (del. 13 splicing buffer (60 mM potassium phosphate (pH 7.0), 3% PEG
41–74) (Frank et al., 1994); 95–1312, 59ACACCCGGATGGCCATGTT 8000, 2.5 mM MgCl2, 2 mM ATP) with 1 mM each 94–6299 and
CGTTA (del. 88–106); 95–1313, 59GACAACACCCGGGTTCGTTAT 95–2211 oligonucleotides (water replaced the oligonucleotides in
AAG (del. 84–110); 95–1318, 59CCGGATGGTTCTCCATTTTCCGTAG control reactions). The depleted extracts were placed on ice prior
AACCATGTTC (reverse complement 92–102); 95–4443, 59CCCGGAT to reconstitution. Reconstitution was performed at 238C for 5–7 min
GGTTCTTGCGAACCATGTTCG (del. 91–103 replaced GCAA); in a reaction containing 4 ml depleted extract and 0.5 ml of 200–500
95–4444, 59CCCGGATGGTTCCGAAGAACCATGTTCG (del. 91–103 nM in vitro transcribed snRNA. Splicing was initiated by addition of
replaced UUCG); 95–4448, 59GATGGTTCTGGTGCAAGAACCATG 0.5 ml 23 splice buffer containing 2 nM 32P-labeled actin or ligated
(del. 95–99); and 96–2380, 59GATGGTTCTGGTCCCCGGCAAGAA CYH2 pre-mRNA to reactions at 238C followed by incubation for a
CCA (96–99 replaced GGGG). Oligonucleotides used for primer ex- further 20 min. Splicing reactions were then processed according
tension were 93–4696, 59AAAAATATGGCAGGCCTACAGTAACGG to Newman et al. (1985). UV cross-linking and RNaseH analysis of
for U5 snRNA and 94–1033, 59AAACGAAATAAATCTCT for U6 cross-links was performed according to Newman et al. (1995).
snRNA. Oligonucleotides used for PCR of U5 snRNA gene se-
quences from plasmid m571 to produce in vitro transcription tem- Primer Extension Analysis and Cross-Link Mapping
plates for T7 RNApolymerase were 93–4548,59GCGCTAATACGACT Primer extension analysis of oligonucleotide treated extracts and
CACTATAGGAAGCAGCTTTACAGATCAAT (T7 forward primer) and cross-links was performed essentially according to Newman et al.
89–1959, 59AACGCCCTCCTTACTCATTG (back primer). Oligonucle- (1995).
otides used for PCR of U1 snRNA gene sequences from plasmid
k461 to produce in vitro transcription templates for T7 RNA polymer- Two-Dimensional Electrophoresis
ase were94–2929, 59GCTAATACGACTCACTATAGATACTTACCTTA Reconstitution reactions and UV cross-linking for 2-D gel analysis
AGATATCA (T7 forward primer) and 94–2861, 59AAAATA AATCAAAA were performed as described above except for the following: the
ATTATAAGATCC (back primer). Oligonucleotides used for PCR of 4-thioU containing CYH2 pre-mRNA was made by ligation as de-
the two fragments of U5 snRNA from m571 to produce in vitro scribed (Newman et al., 1995) with a synthetically produced 59 tran-
transcription templates for T7 RNA polymerase were 93–4548, (T7 script of 25 nucleotides and a G→C mutation at the last nucleotide
forward primer, see above) and 95- 1331, 59GGAACCATGTTCGTTA of the intron of the 39 transcript to block the second step of splicing.
TAAG (backprimer) for the 59 U5 fragment and95–1317, 59GCGCTAA These changes facilitated identification of U5:exon 1 intermediate
TACGACTCACTATAGGAACCATCCGGGTGTTG (T7 forward primer) cross-links from reconstitution reactions. Reactions were fraction-
and 89–1959, (back primer, see above) for the 39 fragment. Biotinyl- ated in 4%-polyacrylamide-8M urea in the first dimension and 8%-
ated oligonucleotide used for selection of U5 snRNA from splicing polyacrylamide-8M urea in the second dimension and visualized by
reactions with streptavidin-conjugated paramagnetic particles was autoradiography of fixed and dried gels.
94–6170,59biotinATGGCAAGCCCACAGTAACGGACAGC. Synthetic
RNA used to produce CYH2 pre-mRNA by ligation for the 2-D gel Acknowledgments
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